Twist Bioscience (TWST) Share-based Compensation (2017 - 2026)

Twist Bioscience has disclosed Share-based Compensation across 10 years of filings, most recently posting $18.9 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 6.85% year-over-year to $18.9 million; the TTM figure through Mar 2026 stood at $64.3 million (up 10.19% YoY), while the FY2025 annual figure was $64.5 million, up 26.58% from the prior year.
• Share-based Compensation rose to $18.9 million in Q1 2026, from $13.3 million in the prior quarter.
• Over the last five years, Share-based Compensation for TWST reached as high as $22.5 million in Q1 2022 and fell as low as -$2.3 million in Q4 2022.
• The 5-year median for Share-based Compensation is $13.7 million (2024), against an average of $14.1 million.
• Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 112.84% — and 2023, when it soared 573.98%.
• A 5-year view of Share-based Compensation shows it stood at -$2.3 million in 2022, then soared by 573.98% to $11.0 million in 2023, then gained by 8.81% to $12.0 million in 2024, then climbed by 10.69% to $13.3 million in 2025, then surged by 42.67% to $18.9 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $18.9 million, $13.3 million, and $16.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.